Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (18551)
All Articles published online
|
Publishing Process of This Article
|
Nov 26, 2015 (publication date) through Jun 8, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Cardiology
ISSN
1949-8462
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yu LM, Xu Y. Epigenetic regulation in cardiac fibrosis. World J Cardiol 2015; 7(11): 784-791 [PMID: 26635926 DOI: 10.4330/wjc.v7.i11.784] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v7/i11/784.htm |
| Number | Citing Articles |
| 1 |
Hongliang Dai, Guizhi Jia, Meili Lu, Chunguang Liang, Yue Wang, Hongxin Wang. Astragaloside IV inhibits isoprenaline-induced cardiac fibrosis by targeting the reactive oxygen species/mitogen-activated protein kinase signaling axis. Molecular Medicine Reports 2017; 15(4): 1765 doi: 10.3892/mmr.2017.6220
|
| 2 |
Seth Mikaye Monayo, Xin Liu. The Prospective Application of Melatonin in Treating Epigenetic Dysfunctional Diseases. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.867500
|
| 3 |
R. Erik Edens, Peter J. Gruber. Fibrosis in Fontan physiology. The Journal of Thoracic and Cardiovascular Surgery 2016; 151(6): 1527 doi: 10.1016/j.jtcvs.2016.02.002
|
| 4 |
Jing-jing Ji, Ling-lin Qian, Yi Zhu, Yu Jiang, Jia-qi Guo, Ya Wu, Zi-wei Yang, Yu-yu Yao, Gen-shan Ma. Kallistatin/Serpina3c inhibits cardiac fibrosis after myocardial infarction by regulating glycolysis via Nr4a1 activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2022; 1868(9): 166441 doi: 10.1016/j.bbadis.2022.166441
|
| 5 |
Ares Pasipoularides. Calcific Aortic Valve Disease: Part 2—Morphomechanical Abnormalities, Gene Reexpression, and Gender Effects on Ventricular Hypertrophy and Its Reversibility. Journal of Cardiovascular Translational Research 2016; 9(4): 374 doi: 10.1007/s12265-016-9695-z
|
| 6 |
Vincenzo Grimaldi, Maria Rosaria De Pascale, Alberto Zullo, Andrea Soricelli, Teresa Infante, Francesco Paolo Mancini, Claudio Napoli. Evidence of epigenetic tags in cardiac fibrosis. Journal of Cardiology 2017; 69(2): 401 doi: 10.1016/j.jjcc.2016.10.004
|
| 7 |
Chunkun Yang, Qingquan Pan, Kui Ji, Zhuang Tian, Hongyuan Zhou, Shuanghong Li, Chuanchao Luo, Jun Li. Review on the protective mechanism of astragaloside IV against cardiovascular diseases. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1187910
|
| 8 |
Suresh K. Verma, Venkata N.S. Garikipati, Prasanna Krishnamurthy, Sarah M. Schumacher, Laurel A. Grisanti, Maria Cimini, Zhongjian Cheng, Mohsin Khan, Yujia Yue, Cindy Benedict, May M. Truongcao, Joseph E. Rabinowitz, David A. Goukassian, Douglas Tilley, Walter J. Koch, Raj Kishore. Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell–Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium. Circulation 2017; 136(10): 940 doi: 10.1161/CIRCULATIONAHA.117.027889
|
| 9 |
Hui Tao, Zheng-Yu Song, Xuan-Sheng Ding, Jing-Jing Yang, Kai-Hu Shi, Jun Li. Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification. Heart Failure Reviews 2018; 23(5): 789 doi: 10.1007/s10741-018-9694-z
|
| 10 |
Grazia Maria Virzì, Anna Clementi, Alessandra Brocca, Massimo de Cal, Claudio Ronco. Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes. Journal of Nephrology 2018; 31(3): 333 doi: 10.1007/s40620-017-0425-7
|
| 11 |
Melisse Erasmus, Ebrahim Samodien, Sandrine Lecour, Martin Cour, Oscar Lorenzo, Phiwayinkosi Dludla, Carmen Pheiffer, Rabia Johnson. Linking LOXL2 to Cardiac Interstitial Fibrosis. International Journal of Molecular Sciences 2020; 21(16): 5913 doi: 10.3390/ijms21165913
|
| 12 |
Sha Li, Mingjiang Li, Xin Yi, Furong Guo, Yanli Zhou, Suqin Chen, Xian Wu. TRPM7 channels mediate the functional changes in cardiac fibroblasts induced by angiotensin II. International Journal of Molecular Medicine 2017; 39(5): 1291 doi: 10.3892/ijmm.2017.2943
|
| 13 |
Guizhi Jia, Bin Leng, Hongxin Wang, Hongliang Dai. Inhibition of cardiotrophin-1 overexpression is involved in the anti-fibrotic effect of Astrogaloside IV. Molecular Medicine Reports 2017; 16(6): 8365 doi: 10.3892/mmr.2017.7676
|
| 14 |
Shengxiang Liu, Guokang Yang, Yupeng Huang, Cheng Zhang, Hongyan Jin. Predictive value of LncRNA on coronary restenosis after percutaneous coronary intervention in patients with coronary heart disease. Medicine 2021; 100(1): e24114 doi: 10.1097/MD.0000000000024114
|